Related Experiment Video
Updated: Mar 24, 2026

COVID-19 Seroprevalence Test for IgG Antibody Levels Among Healthy Donors Across Different Pandemic Phases in Jeddah
Published on: June 24, 2025
Long-term laboratory-based surveillance of TORCH seroprevalence: A nine-year analysis of 188,251 routine diagnostic
Pınar Etiz1, Salih Çetiner2, Hülya Binokay3
1Cukurova University, Abdi Sütcü Vocational School of Health Services, 01330 Adana, Türkiye.
Background:
Large-scale, long-term serological data are essential for accurately monitoring temporal changes in population immunity and exposure to TORCH pathogens. The aim of this study was to evaluate nine-year temporal trends in IgG and IgM seroprevalence of TORCH-related pathogens using a large, routine laboratory-based dataset, and to assess age- and sex-related differences in seropositivity.
Methods:
This retrospective study analyzed TORCH-related serological test requests performed at a tertiary-care hospital in southern Türkiye between 2015 and 2023. A total of 188,251 serological tests for Toxoplasma gondii, Rubella virus, Cytomegalovirus, and Herpes Simplex Virus (HSV)-1/2 IgG and IgM were reviewed. Chemiluminescent microparticle immunoassay was performed to detect Toxoplasma gondii, Rubella virus, and CMV IgG and IgM, while Triturus fully automated ELISA system was performed to detect HSV-1/2 IgM antibodies. Temporal trends, age- and sex-related differences, and independent predictors of seropositivity were assessed using descriptive statistics and multivariable logistic regression.
Results:
Marked pathogen-specific temporal changes were observed over the nine years. Toxoplasma gondii and rubella IgG seropositivity declined, whereas Cytomegalovirus IgG seropositivity increased steadily, while IgM seropositivity remained consistently low for all TORCH pathogens. Age and sex were significant, pathogen-dependent predictors of seropositivity. The large sample size and extended observation period allowed reliable assessment of year-to-year variations.
Conclusion:
This study, based on one of the largest and longest uninterrupted laboratory-based TORCH datasets reported to date, demonstrates significant pathogen-specific shifts in seroprevalence over time. Routine laboratory data provide a valuable resource for monitoring population-level immunity and supporting public health planning and diagnostic practice.
More Related Videos
06:13Enzyme-linked Immunospot Assay ELISPOT: Quantification of Th-1 Cellular Immune Responses Against Microbial Antigens
Published on: November 23, 2010
15:57Application of Long-term cultured Interferon-γ Enzyme-linked Immunospot Assay for Assessing Effector and Memory T Cell Responses in Cattle
Published on: July 11, 2015
Related Concept Videos
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Principles of Disease Surveillance
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...